BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
NASDAQ:BWAY - Nasdaq - US10501L1061 - ADR - Currency: USD
BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. An interesting combination arises when we look at growth and value: BWAY is growing strongly while it also seems undervalued. These ratings could make BWAY a good candidate for value and growth investing.
1. Profitability
1.1 Basic Checks
In the past year BWAY was profitable.
In the past year BWAY had a positive cash flow from operations.
BWAY had negative earnings in 4 of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of BWAY (3.11%) is better than 79.37% of its industry peers.
Looking at the Return On Equity, with a value of 4.69%, BWAY is in the better half of the industry, outperforming 79.89% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.49%, BWAY is doing good in the industry, outperforming 69.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.11% | ||
| ROE | 4.69% | ||
| ROIC | 1.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BWAY has a better Profit Margin (7.12%) than 80.42% of its industry peers.
BWAY's Operating Margin of 3.39% is fine compared to the rest of the industry. BWAY outperforms 69.84% of its industry peers.
With an excellent Gross Margin value of 74.56%, BWAY belongs to the best of the industry, outperforming 87.83% of the companies in the same industry.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.39% | ||
| PM (TTM) | 7.12% | ||
| GM | 74.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for BWAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 3.75 indicates that BWAY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.75, BWAY is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
BWAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.75 |
ROIC/WACC0.16
WACC9.06%
2.3 Liquidity
BWAY has a Current Ratio of 5.31. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY has a Current ratio of 5.31. This is in the better half of the industry: BWAY outperforms 76.19% of its industry peers.
A Quick Ratio of 5.02 indicates that BWAY has no problem at all paying its short term obligations.
With a decent Quick ratio value of 5.02, BWAY is doing good in the industry, outperforming 78.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.31 | ||
| Quick Ratio | 5.02 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 268.04%, which is quite impressive.
The Revenue has grown by 29.04% in the past year. This is a very strong growth!
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)268.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%25.07%
3.2 Future
BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.62% yearly.
BWAY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.51% yearly.
EPS Next Y32.06%
EPS Next 2Y23.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.2%
Revenue Next 2Y20.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.31 indicates a correct valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued cheaper than 85.71% of the companies in the same industry.
When comparing the Price/Earnings ratio of BWAY to the average of the S&P500 Index (25.91), we can say BWAY is valued slightly cheaper.
The Price/Forward Earnings ratio is 11.57, which indicates a very decent valuation of BWAY.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 87.83% of the companies in the same industry.
BWAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.31 | ||
| Fwd PE | 11.57 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 68.78% of the companies are valued more expensively.
80.42% of the companies in the same industry are more expensive than BWAY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.11 | ||
| EV/EBITDA | 43.09 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 23.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y23.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (5/23/2025, 5:20:01 PM)
10.73
+0.3 (+2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.22%
Inst Owner Change1.22%
Ins Owners16.75%
Ins Owner ChangeN/A
Market Cap202.50M
Analysts85.71
Price Target0.08 (-99.25%)
Short Float %0.62%
Short Ratio2.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.08%
Min Revenue beat(2)0.01%
Max Revenue beat(2)0.15%
Revenue beat(4)3
Avg Revenue beat(4)-0.22%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)0.82%
Revenue beat(8)6
Avg Revenue beat(8)-7.18%
Revenue beat(12)6
Avg Revenue beat(12)-29.43%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.51%
PT rev (3m)5.15%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-5.21%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)1.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.31 | ||
| Fwd PE | 11.57 | ||
| P/S | 4.94 | ||
| P/FCF | 31.11 | ||
| P/OCF | 19.79 | ||
| P/B | 3.25 | ||
| P/tB | 3.25 | ||
| EV/EBITDA | 43.09 |
EPS(TTM)0.75
EY6.99%
EPS(NY)0.93
Fwd EY8.64%
FCF(TTM)0.34
FCFY3.21%
OCF(TTM)0.54
OCFY5.05%
SpS2.17
BVpS3.3
TBVpS3.3
PEG (NY)0.45
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.11% | ||
| ROE | 4.69% | ||
| ROCE | 1.76% | ||
| ROIC | 1.49% | ||
| ROICexc | 12.15% | ||
| ROICexgc | 12.15% | ||
| OM | 3.39% | ||
| PM (TTM) | 7.12% | ||
| GM | 74.56% | ||
| FCFM | 15.87% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 219.07% | ||
| Cap/Sales | 9.07% | ||
| Interest Coverage | 11.13 | ||
| Cash Conversion | 331.07% | ||
| Profit Quality | 222.8% | ||
| Current Ratio | 5.31 | ||
| Quick Ratio | 5.02 | ||
| Altman-Z | 3.75 |
F-Score6
WACC9.06%
ROIC/WACC0.16
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)268.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y32.06%
EPS Next 2Y23.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%25.07%
Revenue Next Year19.2%
Revenue Next 2Y20.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y690.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y696.73%
OCF growth 3Y126.53%
OCF growth 5YN/A